The Federal Court has accepted admissions by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd (GSK) and Novartis Consumer Health Australasia Pty Ltd (Novartis) that they breached the Australian Consumer Law by making false or misleading representations in the marketing of Voltaren Osteo Gel and Voltaren Emulgel pain relief products.
An appeal by the ACCC against a Federal Court judgment in relation to Medibank Private Limited (Medibank) has been dismissed by the Full Federal Court.
A range of complex issues affecting home, contents and strata insurance markets in northern Australia mean residents and property owners pay much higher premiums than is the case elsewhere in Australia, according to a new report by the ACCC.
The Federal Court has ruled that the encapsulation in Australia of imported fish oil and Vitamin D by Nature's Care Manufacture Pty Ltd (Nature’s Care) would not permit the capsules to be labelled ‘Made in Australia’ under the Australian Consumer Law’s (ACL) Country of Origin labelling provisions.
The Federal Government has directed the ACCC to monitor and report on the prices, costs and profits relating to the supply of menstrual products in the feminine hygiene products industry.
Many people are either abandoning their private health insurance policies or downgrading to lower-cost, lower-benefit products as premium increases continue to outpace inflation and wage growth.
This report analyses key competition and consumer developments and trends in the private health insurance industry between 1 July 2017 and 30 June 2018.
The ACCC has sought Special Leave from the High Court to appeal the Full Federal Court‘s judgment of 25 May 2018 which upheld the dismissal of allegations against Pfizer Australia Pty Ltd (Pfizer) by the trial judge.
Frustration with complex private health insurance policies and unexpected out-of-pocket costs is leading to increased complaints and even some people abandoning their hospital policies.
This report analyses key competition and consumer developments and trends in the private health insurance industry between 1 July 2016 and 30 June 2017, including ACCC enforcement and other actions relating to the health sector.